A Canadian real-world, multi-center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2-negative advanced breast cancer

  1. Catherine Doyle
  2. Ana Elisa Lohmann
  3. Nayyer Iqbal
  4. Jan-Willem Henning
  5. Swati Kulkarni
  6. Nadia Califaretti
  7. John Hilton
  8. Cristiano Ferrario
  9. Nathaniel Bouganim
  10. Mihaela Mates
  11. Stephanie Guillemette
  12. Ricardo Leite
  13. Marc-Andre Caron
  14. Francois Thireau
  15. Andres Machado
  16. Stephen Chia
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1007/s10549-024-07580-8
  2. Version published to 10.21203/rs.3.rs-4655101/v1 on Research Square